Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Other Info
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    ₹500
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹75 Cr
  • Created on
    3 Oct 2021
Fund Ranking
#10
/ 19 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    8.9%
  • 1 Year
    6.6%
  • 3 Year (CAGR)
    18.5%
  • All Time (CAGR)
    13.3%
Category Return
  • 6 Month
    10.9%
  • 1 Year
    8.5%
  • 3 Year (CAGR)
    18.8%
  • All Time (CAGR)
    16.8%
Asset Allocation
  • Equity
    100.0%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    7.45%
  • Aurobindo Pharma
    4.08%
  • Cipla
    6.69%
  • Dr. Reddy's Laboratories
    6.64%
  • Ipca Laboratories
    2.36%
Fund Information
  • Expense Ratio
    0.22%
  • Exit Load
    No Exit Load
  • Lock-In Period
    No Lock-In

Managed By

Pranav Gupta
June 2022 - Present
Haresh Mehta
March 2023 - Present
Rupesh Gurav
Nov 2024 - Present
Priya Sridhar
Dec 2024 - Present
Mehul Dama
July 2026 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.79
  • Standard Deviation
    16.87
  • Alpha
    -1.81
  • Beta
    1.00
Disclaimer: Mutual fund investments are subject to market risks, read all scheme related documents carefully.